| Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination (NCT05414890) | Beijing Tiantan Hospital | 2022-06-30 |
| A Study of LP-168 in Healthy Volunteers (NCT05432713) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2022-05-14 |
| Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) (NCT05145361) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-04-07 |
| China National Registry of Neuro-Inflammatory Diseases (NCT05154370) | Beijing Tiantan Hospital | 2021-12-15 |
| Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders (NCT05154734) | Tianjin Medical University General Hospital | 2021-12-12 |
| Biorepository and Registry for Plasma Exchange Patients (NCT05004493) | Charles M Knudson | 2021-07-28 |
| Imaging Evaluation of Central Nervous Autoimmune Diseases (NCT04822623) | Qilu Hospital of Shandong University | 2021-05-01 |
| National, Multicentric Registry Study on Neuroimmunological Diseases in China (NCT06443333) | Xuanwu Hospital, Beijing | 2020-12-01 |
| Epidemiological Characteristics of COVID-19 in Patients With MS or NMO (NCT04355611) | Assistance Publique - Hôpitaux de Paris | 2020-04-17 |
| A Study of HBM9161 in NMOSD Patients (NCT04227470) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-03-31 |
| Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder (NCT05896605) | First Affiliated Hospital of Guangxi Medical University | 2020-01-01 |
| Autologous Transplant To End NMO Spectrum Disorder (NCT03829566) | Northwestern University | 2019-11-01 |
| Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE) (NCT04106830) | Beijing Tiantan Hospital | 2019-01-01 |
| Pediatric NMOSD Observational Study (NCT03766347) | Mayo Clinic | 2018-02-01 |